Harm reduction in prisons: A 'rights based analysis'

Critical Public Health

Volumn 14, Issue 4, 2004, Pages 345-360

  Kerr, Thomas ^a,b   Wood, Evan ^b,c   Betteridge, Glenn ^a   Lines, Rick ^d   Jürgens, Ralf ^a  

^a Canadian HIV/AIDS Legal Network   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Irish Penal Reform Trust   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; ILLICIT DRUG; METHADONE; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; COMMUNITY CARE; DISEASE TRANSMISSION; DRUG ABSORPTION; DRUG ABUSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG WITHDRAWAL; GOVERNMENT; HARM REDUCTION; HEALTH EDUCATION; HEALTH HAZARD; HEALTH PROGRAM; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; LAW; LAW ENFORCEMENT; MAINTENANCE THERAPY; NEEDLE; OPIATE ADDICTION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRISON; PRISONER; PROTECTION; REVIEW; SAFETY;

EID: 17144392149     PISSN: 09581596     EISSN: None     Source Type: Journal    
DOI: 10.1080/09581590400027478     Document Type: Review

References (112)

1. Abdala, N., Gleghorn, A.A., Carney, J.M. & Heimer, R. (2001) Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. Journal of Acquired Immune Deficiency Syndrome, 28, pp. 487-494.
2. Allwright, S., Bradley, F., Long, J., Barry, J., Thornton, L. & Parry, J.V. (2000) Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. British Medical Journal, 321, pp. 78-82.
3. Babudieri, S., Starnini, G., Brunetti, B., Carbonara, S., D'Offizi, G.P., Monarca, R., Mazzarello, G., Novati, S., Casti, A., Florenzano, G., Quercia, G., Iovinella, E., Sardu, C., Romano, A., Dierna, M., Vullo, S., Pintus, A., Maida, I., Dori, L., Ardita, S., Mura, M.S., Andreoni, M. & Rezza, G. (2003) [HIV and related infections in Italian penal institutions: epidemiological and health organization note]. Annual Ist Super Sanita, 39, pp. 251-257.
4. Ball, A. (1995) Multi-Centre Study on Drug Injecting and Risk of HIV Infection, a report prepared on behalf of the International Collaborative Group for the World Health Organization Programme on Substance Abuse (Geneva, World Health Organization).
5. Ball, J. & Ross, A. (1991) The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services and Outcomes (New York, Springer-Verlag).
6. Bertschy, G. (1995) Methadone maintenance treatment: an update. European Archives of Psychiatry & Clinical Neuroscience, 245, pp. 114-124.
7. Bluthenthal, R.N., Kral, A.H., Gee, L., Erringer, E.A. & Edlin, B.R. (2000) The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS, 14, pp. 605-611.
8. Bollini, P., Laporte, J.D. & Harding, T.W. (2002) HIV prevention in prisons. Do international guidelines matter? European Journal Public Health, 12, pp. 83-89.
9. Broadhead, R.S., Heckathorn, D.D., Grund, J.C., Stern, L.S. & Anthony, D.L. (1995) Drug users versus outreach workers in combating AIDS: preliminary results of a peer-driven intervention. Journal of Drug Issues, 25, pp. 531-564.
10. Broadhead, R.S., Heckathorn, D.D., Weakliem, D.L., Anthony, D.L., Madray, H., Mills, R.J. & Hughes, J. (1998) Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Reports, 113 (Suppl 1), pp. 42-57.
11. Burattini, M., Massad, E., Rozman, M., Azevedo, R. & Carvalho, H. (2000) Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison. Revista Saúde Publica, 34, pp. 431-436.
12. Byrne, A. & Dolan, K. (1998) Methadone treatment is widely accepted in prisons in New South Wales. British Medical Journal, 316, pp. 1744-1745.
13. Calzavara, L.M., Burchell, A.N., Schlossberg, J., Myers, T., Escobar, M., Wallace, E., Major, C., Strike, C. & Millson, M. (2003) Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction, 98, pp. 1257-1265.
14. Carvell, A.L. & Hart, G.J. (1990) Risk behaviours for HIV infection among drug users in prison. British Medical Journal, 300, pp. 1383-1384.
15. Chang, C.J., Lin, C.H., Lee, C.T., Chang, S.J., Ko, Y.C. & Liu, H.W. (1999) Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. European Journal of Epidemiology, 16, pp. 1043-1049.
16. Choopanya, K., Des Jarlais, D.C., Vanichseni, S., Kitayaporn, D., Mock, P.A., Raktham, S., Hireanras, K., Heyward, W.L., Sujarita, S. & Mastro, T.D. (2002) Incarceration and risk for HIV infection among injection drug users in Bangkok. Journal of Acquired Immune Deficiency Syndrome, 29, pp. 86-94.
17. Clarke, J.G., Stein, M.D., Hanna, L., Sobota, M. & Rich, J.D. (2001) Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Substance Abuse, 22, pp. 209-216.
18. Correctional Service of Canada (1994) HIV/AIDS in Prisons: Final report of the Expert Committee on AIDS and Prisons (Ottawa, Minister of Supply and Services).
19. Crofts, N., Hopper, J.L., Bowden, D.S., Breschkin, A.M., Milner, R. & Locarnini, S.A. (1993) Hepatitis C virus infection among a cohort of Victorian injecting drug users. Medical Journal of Australia 159, pp. 237-241.
20. Darke, S., Kaye, S. & Finlay-Jones, R. (1998) Drug use and injection risk-taking among prison methadone maintenance patients, Addiction, 93, pp. 1169-1175.
21. Des Jarlais, D.C., Hagan, H., Friedman, S.R., Friedmann, P., Goldberg, D., Frischer, M., Green, S., Tunving, K., Ljungberg, B., Wodak, A. et al. (1995) Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association 274, pp. 1226-1231.
22. Des Jarlais, D.C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., Jose, B. & Friedman, S.R. (1996) HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348, pp. 987-991.
23. Dolan, K. (1999) National Drug and Alcohol Research Centre, Sydney.
24. Dolan, K., Hall, W. & Wodak, A. (1996) Methadone maintenance reduces injecting in prison. British Medical Journal, 312, p. 1162.
25. Dolan, K., Rutter, S. & Wodak, A.D. (2003a) Prison-based syringe exchange programmes: a review of international research and development. Addiction, 98, pp. 153-158.
26. Dolan, K., Wodak, A. & Penny, R. (1995) AIDS behind bars: preventing HIV spread among incarcerated drug injectors. AIDS, 9, pp. 825-832.
27. Dolan, K.A., Shearer, J., MacDonald, M., Mattick, R.P., Hall, W. & Wodak, A.D. (2003b) A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug and Alcohol Dependency, 72, pp. 59-65.
28. Dolan, K.A. & Wodak, A. (1999) HIV transmission in a prison system in an Australian State. Medical Journal of Australia, 171, pp. 14-17.
29. Dolan, K.A., Wodak, A.D. & Hall, W.D. (1998) A bleach program for inmates in NSW: an HIV prevention strategy. Australian and New Zealand Journal of Public Health, 22, pp. 838-840.
30. Dole, V.P., Robinson, J.W., Orraca, J., Towns, E., Searcy, P. & Caine, E. (1969) Methadone treatment of randomly selected criminal addicts. New England Journal of Medicine, 280, pp. 1372-1375.
31. Drucker, E. (1999) Drug prohibition and public health: 25 years of evidence. Public Health Reports, 114, pp. 14-29.
32. Drucker, E., Lurie, P., Wodak, A. & Alcabes, P. (1998) Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS, 12, pp. S217-230.
33. Dubler, N., Bergmann, C. & Frankel, M. (1990) Management of HIV Infection in New York State Prisons. Columbia Human Rights Law Review, 21, pp. 363-365.
34. Duhamel, A.R.J., Nuttens, M.C., Devos, P., Beuscart, R. & Archer, E. (2001) Social and health status of arrivals in a French prison: a consecutive case study from 1989 to 1995. Revue d'Epidemiologique et de Santé Publique, 49, pp. 229-238.
35. Ehrmann, T. (2002) Community-based organizations and HIV prevention for incarcerated populations: three HIV prevention program models. AIDS Education and Prevention, 14, pp. 75-84.
36. European Network on HIV/AIDS and Hepatitis Prevention in Prisons (1997) Final Report on the EU Project European Network on HIV/AIDS Prevention in Prisons, Bonn and Marseille.
37. Ezard, N. (2001) Public health, human rights and the harm reduction paradigm: from risk reduction to vulnerability reduction. International Journal of Drug Policy, 12, pp. 207-219.
38. Fasher, A.M., Dunbar, N., Rothenbury, B.A., Bebb, D.K. & Young, S.J. (1997) The health of a group of young Australians in a New South Wales juvenile justice detention centre: a pilot study. Journal of Paediatrics and Child Health, 33, pp. 426-429.
39. Fischer, B., Gliksman, L., Rehm, J., Daniel, N. & Medved, W. (1999) Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort. Canadian Journal of Public Health, 90, pp. 299-303.
40. Fischer, B., Rehm, J., Kirst, M., Casas, M., Hall, W., Krausz, M., Metrebian, N., Reggers, J., Uchtenhagen, A., van den Brink, W. & van Ree, J.M. (2002) Heroin-assisted treatment as a response to the public health problem of opiate dependence. European Journal of Public Health, 12, pp. 228-234.
41. Flanigan, T.P., Kim, J.Y., Zierler, S., Rich, J., Vigilante, K. & Bury-Maynard, D. (1996) A prison release program for HIV-positive women: linking them to health services and community follow-up. American Journal of Public Health, 86, pp. 886-887.
42. Frost, L. & Tchertkov, V. (2002) Prisoner risk taking in the Russian Federation. AIDS, Education and Prevention, 14, pp. 7-23.
43. Gibson, D., NM, N.F. & McCarthy, J. (1999) Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 13, pp. 1807-1818.
44. Godin, G., Gagnon, H., Alary, M., Noel, L. & Morissette, M.R. (2001) Correctional officers' intention of accepting or refusing to make HIV preventive tools accessible to inmates. AIDS Education and Prevention, 13, pp. 462-473.
45. Goldberg, D., Taylor, A., McGregor, J., Davis, B., Wrench, J. & Gruer, L. (1998) A lasting public health response to an outbreak of HIV infection in a Scottish prison? International Journal STD and AIDS, 9, pp. 25-30.
46. Hagan, H., Jarlais, D.C., Friedman, S.R., Purchase, D. & Alter, M.J. (1995) Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health, 85, pp. 1531-1537.
47. Hagan, H. & Thiede, H. (2003) Does bleach disinfection of syringes help prevent hepatitis C virus transmission? Epidemiology, 14, pp. 628-629; author reply p. 629.
48. Hagan, H., Thiede, H., Weiss, N.S., Hopkins, S.G., Duchin, J.S. & Alexander, E.R. (2001) Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, pp. 42-46.
49. Hammett, T.M. (1988) AIDS in Correctional Facilities: Issues and Options (Washington, DC, US Department of Justice).
50. Hammett, T.M., Harmon, M.P. & Rhodes, W. (2002) The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. American Journal of Public Health, 92, pp. 1789-1794.
51. Harding, T.W. & Schaller, G. (1992) In: Netter, T. (ed.) AIDS in the World (Cambridge, MA, Harvard University Press), pp. 761-769.
52. Hartel, D.M. & Schoenbaum, E.E. (1998) Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Reports, 113, pp. 107-115.
53. Hiller, M.L., Knight, K. & Simpson, D.D. (1999) Prison-based substance abuse treatment, residential aftercare and recidivism. Addiction, 94, pp. 833-842.
54. Human Rights Committee (1989) General Comment 7(16). United Nations.
55. Hunt, D., Lipton, D., Goldsmith, D., Strug, D. & B.S. (1986) It takes your heart: the image of methadone maintenance in the addict world and its effects on recruitment into treatment. International Journal of the Addictions, 20, pp. 1751-1771.
56. Hurley, S.F., Jolley, D.J. & Kaldor, J.M. (1997) Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349, pp. 1797-1800.
57. Hutchinson, S.J., Goldberg, D.J., Gore, S.M., Cameron, S., McGregor, J., McMenamin, J. & McGavigan, J. (1998) Hepatitis B outbreak at Glenochil prison during January to June 1993. Epidemiological Infection, 121, pp. 185-191.
58. Jürgens, R. (1996) HIV/AIDS in Prisons: Final Report (Montreal, Canadian HIV/AIDS Legal Network).
59. Kale, K.M., Jogdand, G.S. & Aswar, N.R. (1999) Sociomedical problems of institutionalised women. Indian Journal of Medical Sciences, 53, pp. 162-166.
60. Kallas, E.G., Varella, D., Ceneviva, A.C. & Castelo, A. (1998) HIV seroprevalence and risk factors in a Brazilian prison. Brazilian Journal of Infectious Diseases, 2, pp. 197-204.
61. Koester, S., Anderson, K. & Hoffer, L. (1999) Active heroin injectors' perceptions and use of methadone maintenance treatment: cynical performance or self-prescribed risk reduction? Substance Use & Misuse, 34, pp. 2135-2153.
62. Koulierakis, G., Gnardellis, C., Agrafiotis, D. & Power, K.G. (2000) HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction, 95, pp. 1207-1216.
63. Leary, V. (1994) The right to health in international human rights law. Health and Human Rights, 1, pp. 24-56.
64. Leshner, A.I. (1997) Addiction is a brain disease, and it matters. Science, 278, pp. 45-47.
65. Lines, R. (2002a) Canadian HIV/AIDS Legal Network, Montreal.
66. Lines, R. (2002b) Prisoners' HIV/AIDS Support Action Network, Toronto.
67. Lines, R., Jürgens, R., Stover, H., Laticevschi, D. & Nelles, J. (in press) Prison Needle Exchange: A Review of the International Evidence and Experience (Montreal, Canadian HIV/AIDS Legal Network).
68. Lowinson, J., Marion, I., Joseph, H. & Dole, V. (1997) In: Lowinson, J.H., Ruiz, P., Millman, R.B. & Langrod, J.G. (eds) Substance Abuse: A Comprehensive Textbook (Baltimore, Williams & Wilkins), pp. 552-53.
69. Macalino, G.E., Hou, J.C., Kumar, M.S., Taylor, L.E., Sumantera, J.D., Rich, J.D. (2004) Hepatitis C infection and incarcerated populations. International Journal of Drug Policy, 15, pp. 103-114.
70. Malliori, M., Sypsa, V., Psichogiou, M., Touloumi, G., Skoutelis, A., Tassopoulos, N., Hatzakis, A. & Stefanis, C. (1998) A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction, 93, pp. 243-251.
71. McCoy, C.B., Rivers, J.E., McCoy, H.V., Shapshak, P., Weatherby, N.L., Chitwood, D.D., Page, J.B., Inciardi, J.A. & McBride, D.C. (1994) Compliance to bleach disinfection protocols among injecting drug users in Miami. Journal of Acquired Immune Deficiency Syndrome 7, pp. 773-776.
72. McDonald, D. & Thomson, N.J. (1993) Australian deaths in custody, 1980-1989. 2. Causes, Medical Journal of Australia, 159, pp. 581-585.
73. McLellan, A., Arndy, I., Alterman, A., Woody, G. & Metzger, D. (1993) Psychosocial services in substance abuse treatment? A dose-ranging study of psychosocial services. Journal of the American Medical Association, 269, pp. 1953-1959.
74. Metzger, D.S., Woody, G.E., McLellan, A.T., O'Brien, C.P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P. & Abrutyn, E. (1993) Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndrome, 6, pp. 1049-1056.
75. Mino, A., Page, D., Dumont, P. & Broers, B. (1998) Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva. Drug Alcohol Dependency, 50, pp. 233-239.
76. Muller, R., Stark, K., Guggenmoos-Holzmann, I., Wirth, D. & Bienzle, U. (1995) Imprisonment: a risk factor for HIV infection counteracting education and prevention programmes for intravenous drug users. AIDS, 9, pp. 183-190.
77. Canadian HIV/AIDS Legal Network (2004) A Rights-based Approach to HIV/AIDS (Montreal, Canadian HIV/AIDS Legal Network), pp. 1-6. Available online at: http://www.aidslaw.ca/Maincontent/issues/discrimination/ rights_approach_description.pdf
78. Newman, R. (1977) Methadone Treatment in Narcotic Addiction: Program Management, Findings and Prospects for the Future (New York, Academic Press).
79. Newman, R.G. & Whitehill, W.B. (1979) Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet, 2, pp. 485-488.
80. Polonsky, S., Kerr, S., Harris, B., Gaiter, J., Fichtner, R.R. & Kennedy, M.G. (1994) HIV prevention in prisons and jails: obstacles and opportunities. Public Health Reports, 109, pp. 615-625.
81. Rahbar, A.R., Rooholamini, S. & Khoshnood, K. (2004) Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhas, Iran. International Journal of Drug Policy, 15.
82. Raufu, A. (2001) Nigerian prison authorities free HIV positive inmates. AIDS Analysis Africa, 12, p. 15.
83. Rich, J.D., Dickinson, B.P., Macalino, G., Flanigan, T.P., Towe, C.W., Spaulding, A. & Vlahov, D. (1999) Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. Journal of Acquired Immune Deficiency Syndrome, 22, pp. 161-166.
84. Richie, B.E., Freudenberg, N. & Page, J. (2001) Reintegrating women leaving jail into urban communities: a description of a model program. Journal of Urban Health, 78, pp. 290-303.
85. Rosenbaum, M., Washburn, A., Knight, K., Kelley, M. & Irwin, J. (1996) Treatment as harm reduction, defunding as harm maximization: the case of methadone maintenance. Journal of Psychoactive Drugs, 28, pp. 241-249.
86. Rotily, M., Weilandt, C., Bird, S.M., Kall, K., Van Haastrecht, H.J., Iandolo, E. & Rousseau, S. (2001) Surveillance of HIV infection and related risk behaviour in European prisons: a multicentre pilot study. European Journal of Public Health, 11, pp. 243-250.
87. Schaller, G. & Harding, T.W. (1995) [AIDS prevention in European prisons]. Soz Praventivmed, 40, pp. 298-301.
88. Seaman, S.R., Bird, S.M. & Brettle, R.P. (2000) Historical HIV prevalence in Edinburgh Prison: a database-linkage study. Journal of Epidemiological Biostatistics, 5, pp. 245-250.
89. Sees, K.L., Delucchi, K.L., Masson, C., Rosen, A., Clark, H.W., Robillard, H., Banys, P. & Hall, S.M. (2000) Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. Journal of the American Medical Association, 283, pp. 1303-1310.
90. Senay, E. & Uchtenhagen, A. (1990) In: Westermeyer, J. (ed.) Methadone Maintenance in the Management of Opioid Dependence (New York, Praeger).
91. Sheerin, I., Green, T., Sellman, D., Adamson, S. & Deering, D. (2004) Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. New Zealand Medical Journal, 117, p. U795.
92. Shewan, D., Gemmell, M. & Davies, J.B. (1994) Behavioural change amongst drug injectors in Scottish prisons. Social Science and Medicine, 39, pp. 1585-1586.
93. Sibbald, B. (2002) Methadone maintenance expands inside federal prisons. Canadian Medical Association Journal, 167, p. 1154.
94. Small, W., Kain, S., Laliberte, N., Schechter, M., O'Shaughnessy, M. & Spittal, P. (in press) Incarceration, addiction, and harm reduction: inmates' experience of injection drugs in prison. Substance Use and Misuse.
95. Strain, E.C., Bigelow, G.E., Liebson, I.A. & Stitzer, M.L. (1999) Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. _Journal of the American Medical Association, 281, pp. 1000-1005.
96. Strathdee, S.A., Patrick, D.M., Currie, S.L., Cornelisse, P.G., Rekart, M.L., Montaner, J.S., Schechter, M.T. & O'Shaughnessy, M.V. (1997) Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS, 11, pp. F59-65.
97. Taylor, A., Goldberg, D., Emslie, J., Wrench, J., Gruer, L., Cameron, S., Black, J., Davis, B., McGregor, J., Follett, E. et al. (1995) Outbreak of HIV infection in a Scottish prison. British Medical Journal, 310, pp. 289-292.
98. Thaisri, H., Lerwitworapong, J., Vongsheree, S., Sawanpanyalert, P., Chadbanchachai, C., Rojanawiwat, A., Kongpromsook, W., Paungtubtim, W., Sri-Ngam, P. & Jaisue, R. (2003) HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infectious Diseases, 3, p. 25.
99. Tyndall, M.W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M.V. & Schechter, M.T. (2003) Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 17, pp. 887-893.
100. United Nations General Assembly (1990) Basic Principles for the Treatment of Prisoners (New York, United Nations).
101. Vaz, R.G., Gloyd, S. & Trindade, R. (1996) The effects of peer education on STD and AIDS knowledge among prisoners in Mozambique. International Journal of STD and AIDS, 7, pp. 51-54.
102. Vlahov, D., Junge, B., Beilenson, P., Brookmeyer, R.S., Cohn, S. & Armenian, H. (1996) Evaluation of the Baltimore needle exchange program: preliminary results. Paper given at the XI International Conference on AIDS Vancouver, July (abstract no. Mo.D.361).
103. Watkins, K.E., Metzger, D., Woody, G. & McLellan, A.T. (1992) High-risk sexual behaviors of intravenous drug users in- and out-of-treatment: implications for the spread of HIV infection. American Journal of Drug & Alcohol Abuse, 18, pp. 389-398.
104. Wells, E.A., Calsyn, D.A., Clark, L.L., Saxon, A.J. & Jackson, T.R. (1996) Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men. American Journal of Drug & Alcohol Abuse, 22, pp. 509-521.
105. Wilson, S. (2004) The principle of equivalence and the future of mental health care in prisons. British Journal of Psychiatry, 184, pp. 5-7.
106. World Health Organization (1992) Constitution of the World Health Organization (Geneva, WHO).
107. World Health Organization (1993) WHO Guidelines on the HIV Infection and AIDS in prisons (Geneva, WHO).
108. Wood, E., Kerr, T., Spittal, P.M., Tyndall, M.W., O'Shaughnessy, M.V. & Schechter, M.T. (2003) The healthcare and fiscal costs of the illicit drug use epidemic: the impact of conventional drug control strategies and the impact of a comprehensive approach. British Columbia Medical Journal, 45, pp. 130-136.
109. Wood, E., Tyndall, M.W., Spittal, P., Li, K., R.S., H., O'Shaughnessy, M. & Schechter, M.T. (2002) Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International Journal of Drug Policy, 13, pp. 95-102.
110. Yirrell, D.L., Hutchinson, S.J., Griffin, M., Gore, S.M., Leigh-Brown, A.J. & Goldberg, D.J. (1999) Completing the molecular investigation into the HIV outbreak at Glenochil prison. Epidemiological Infections, 123, pp. 277-282.
111. Yirrell, D.L., Robertson, P., Goldberg, D.J., McMenamin, J., Cameron, S. & Leigh Brown, A.J. (1997) Molecular investigation into outbreak of HIV in a Scottish prison. British Medical Journal, 314, pp. 1446-1450.
112. Zule, W. & Desmond, D. (1998) Attitudes toward methadone maintenance: implications for HIV prevention. Journal of Psychoactive Drugs, 30, pp. 89-97.